Cargando…

Trends in the use of antimuscarinics and alpha-adrenergic blockers in women with lower urinary tract symptoms in Taiwan: A nationwide, population-based study, 2007-2012

BACKGROUND: We aim to examine the trend in the use of antimuscarinics and off-label alpha-adrenergic blockers for treatment of lower urinary tract symptoms (LUTS) in a Taiwanese Women Cohort between 2007 and 2012. METHODS: This population-based National Health Insurance Research Database (NHIRD) was...

Descripción completa

Detalles Bibliográficos
Autores principales:	Lin, Yu-Hua, Huang, Wei-Yi, Chang, Chi-Chih, Chen, Yu-Fen, Wu, Ling-Ying, Chang, Hong-Chiang, Huang, Kuo-How
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2019
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6779229/ https://www.ncbi.nlm.nih.gov/pubmed/31589615 http://dx.doi.org/10.1371/journal.pone.0220615

Ejemplares similares

Resource utilization and costs associated with the addition of an antimuscarinic in patients treated with an alpha-blocker for the treatment of urinary symptoms linked to benign prostatic hyperplasia
por: Sicras-Mainar, Antoni, et al.
Publicado: (2017)

Alpha-1 Adrenergic Receptor Blockers for the Treatment of Lower Urinary Tract Symptoms in Women: A Systematic Review and Meta-Analysis
por: Kim, Do Kyung, et al.
Publicado: (2019)

Comparison of antimuscarinic drugs to beta adrenergic agonists in overactive bladder: A literary review
por: Wani, Mudassir M., et al.
Publicado: (2021)

PRISMA-combined α-blockers and antimuscarinics for ureteral stent-related symptoms: A meta-analysis
por: Zhang, Yu-ming, et al.
Publicado: (2017)

Long-acting antimuscarinic therapy in patients with chronic obstructive pulmonary disease receiving beta-blockers
por: Chapman, Kenneth R., et al.
Publicado: (2021)

The use of antimuscarinics, phosphodiesterase type V inhibitors and phytotherapy for lower urinary tract symptoms in men
por: Ng, Kok Kit, et al.
Publicado: (2017)

Use of Antimuscarinics in the Elderly
por: Patel, Bhavin, et al.
Publicado: (2009)

A retrospective analysis comparing persistence and adherence to treatment with free‐ vs fixed‐dose combination of an alpha blocker and an antimuscarinic agent in men with LUTS in Spain
por: Landeira, Margarita, et al.
Publicado: (2020)

Demographic and clinical characteristics of carbon monoxide poisoning: nationwide data between 1999 and 2012 in Taiwan
por: Huang, Chien-Cheng, et al.
Publicado: (2017)

The efficacy and safety of alpha-adrenergic blockers for medical expulsion therapy in patients with ureteral calculi: A meta-analysis of placebo-controlled trials
por: Yu, Ze-Wei, et al.
Publicado: (2021)

High satisfaction with direct switching from antimuscarinics to mirabegron in patients receiving stable antimuscarinic treatment
por: Liao, Chun-Hou, et al.
Publicado: (2016)

Prevalence of Lower Urinary Tract Symptoms in Children with Attention-Deficit/Hyperactivity Disorder: Comparison of Hospital and Population-Based Cohorts of 13,000 Patients
por: Yang, Teng-Kai, et al.
Publicado: (2022)

Alpha-1 blocker use increased risk of subsequent renal cell carcinoma: A nationwide population-based study in Taiwan
por: Sung, Shian-Ying, et al.
Publicado: (2020)

Antepartum urinary tract infection and postpartum depression in Taiwan – a nationwide population-based study
por: Liu, Jui-Ming, et al.
Publicado: (2018)

Perioperative adrenergic response and the use of beta-blockers
por: Kim, Tae-Yop
Publicado: (2014)

The use of alpha-1 adrenergic blockers in children with distal ureterolithiasis: a systematic review and meta-analysis
por: Glina, F.P., et al.
Publicado: (2015)

Effect of the symptom-based alpha-blocker treatment on lower urinary tract symptoms in women: systematic review and meta-analysis
por: Kang, Tae Wook, et al.
Publicado: (2021)

A new tool for self-evaluation of adherence to antimuscarinic drugs treatment in patients with urinary incontinence
por: Kosilov, Kirill V., et al.
Publicado: (2017)

Pharmacist‐driven interventions to de‐escalate urinary antimuscarinics in the Programs of All‐Inclusive Care for the Elderly
por: Ha, Meghan, et al.
Publicado: (2022)

A retrospective study of treatment persistence and adherence to α-blocker plus antimuscarinic combination therapies, in men with LUTS/BPH in the Netherlands
por: Drake, Marcus J., et al.
Publicado: (2017)

Prescription pattern of alpha-blockers for management of lower urinary tract symptoms/benign prostatic hyperplasia
por: Moon, Hyong Woo, et al.
Publicado: (2018)

Molecular Epidemiology of Japanese Encephalitis Virus in Mosquitoes in Taiwan during 2005–2012
por: Su, Chien-Ling, et al.
Publicado: (2014)

Bladder antimuscarinics and cognitive decline in elderly patients
por: Moga, Daniela Claudia, et al.
Publicado: (2017)

Treatment of pediatric antimuscarinic delirium with oral rivastigmine
por: Yakey, Brandtly, et al.
Publicado: (2023)

Factors Associated with Bothersome Lower Urinary Tract Symptoms in Middle-Aged Men Receiving Health Checkup
por: Yang, Teng-Kai, et al.
Publicado: (2019)

Hospital-Owned Apps in Taiwan: Nationwide Survey
por: Liu, Hao-Yen, et al.
Publicado: (2018)

Chronic kidney disease, preoperative use of antispasmodics and lower resected prostate volume ratios are risk factors for postoperative use of adrenergic Alpha-blockers and antispasmodics
por: Hsueh, Chen-Hsun, et al.
Publicado: (2023)

Epidemiology and management of gout in Taiwan: a nationwide population study
por: Kuo, Chang-Fu, et al.
Publicado: (2015)

Epidemiological characteristics of varicella from 2000 to 2008 and the impact of nationwide immunization in Taiwan
por: Chang, Luan-Yin, et al.
Publicado: (2011)

Trends and sex‐specific incidence of upper urinary tract cancer in Taiwan: A birth cohort study
por: Chang, Yu‐Hsuan, et al.
Publicado: (2023)

Community treatment orders and reduced time in hospital: a nationwide study, 2007–2012
por: Taylor, Mark, et al.
Publicado: (2016)

Treatment success for overactive bladder with urinary urge incontinence refractory to oral antimuscarinics: a review of published evidence
por: Campbell, Jonathan D, et al.
Publicado: (2009)

Does atenolol differ from other β-adrenergic blockers?
por: Aursnes, Ivar, et al.
Publicado: (2007)

Can beta-adrenergic blockers be used in the treatment of COVID-19?
por: Vasanthakumar, Natesan
Publicado: (2020)

An Overview of the Clinical Use of Antimuscarinics in the Treatment of Overactive Bladder
por: Athanasopoulos, Anastasios, et al.
Publicado: (2011)

Enterovirus 71 seroepidemiology in Taiwan in 2017 and comparison of those rates in 1997, 1999 and 2007
por: Lee, Jian-Te, et al.
Publicado: (2019)

Bladder Wall Thickness is Associated with Responsiveness of Storage Symptoms to Alpha-Blockers in Men with Lower Urinary Tract Symptoms
por: Park, Jung Soo, et al.
Publicado: (2012)

Changes in autonomic nervous system activity after treatment with alpha-blocker in men with lower urinary tract symptoms
por: Shim, Kang Hee, et al.
Publicado: (2018)

Discontinuation of alpha-blocker therapy in men with lower urinary tract symptoms: a systematic review and meta-analysis
por: van der Worp, Henk, et al.
Publicado: (2019)

Cancer risks of dermatomyositis and polymyositis: a nationwide cohort study in Taiwan
por: Chen, Yi-Ju, et al.
Publicado: (2010)

Cannot write session to /tmp/vufind_sessions/sess_u408o7ji0kadhhih89qk6jr091